recall
saveGE Healthcare Ireland Limited recall (Cls II)
community read0 votes
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91. — Reason: Presence of particulate matter — Status: Ongoing
view source ↗Data sources
last refreshed 3m ago
Found something off?
same company · ±60 days · 6
- recallGE Healthcare Ireland Limited recall (Cls II)Apr 15, 2026
- approvalMILNACIPRAN HYDROCHLORIDE — FDA approvalApr 14, 2026
- approvalDEFLAZACORT — FDA approvalApr 9, 2026
- drug shortageSodium Acetate Injection shortage — Hospira, Inc., a Pfizer CompanyApr 22, 2026
- approvalELTROMBOPAG OLAMINE — FDA approvalApr 8, 2026
- recallAmneal Pharmaceuticals, LLC recall (Cls II)Apr 8, 2026
🐶 often sniffed alongside
top 8- tagRecall10 co-mentions · 9 sources
- tagSmall Molecule7 co-mentions · 6 sources
- drugCHLORPROMAZINE HYDROCHLORIDE4 co-mentions · 4 sources
- drugtrimethoprim3 co-mentions · 2 sources
- drugMAGNESIUM SULFATE2 co-mentions · 1 sources
- drugmagnesium sulfate Pfizer2 co-mentions · 1 sources
- drugmagnesium sulfate Fresenius2 co-mentions · 1 sources
- drugmagnesium2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that